Biohaven provides update on phase 3 trial and multiple system atrophy (msa) program

New haven, conn., sept. 27, 2021 /prnewswire/ -- biohaven pharmaceutical holding company ltd.
BHVN Ratings Summary
BHVN Quant Ranking